Abstract:Study Design.
Retrospective Cohort Study
Objective.
The objective of this study was to compare the rate of adjacent segment disease (ASD) between lumbar disk arthroplasty (LDA) and anterior lumbar interbody fusion (ALIF).
Summary of Background Data.
LDA and ALIF are alternative surgical approaches used to treat lumbar degenerative disk disease. However, there is a paucity of studies comparing the risk of ASD after these procedures.
Methods.
Patients who underwent 1- to 2-level LDA or ALIF between 2010 an… Show more
“…The ICD/CPT codes used to query for ASD were not provided. Specific ICD codes do not exist at each lumbar level (unlike cervical disease), prohibiting querying for adjacent levels. The reported rates may be all-cause subsequent surgeries rather than solely surgeries for ASD secondary to index surgery. The study shows a ~7.5% difference in ASD rate, suggesting ALIF is significantly worse. This may stem from staged ALIF procedures, with the posterior approach occurring several days after the anterior approach. This would overestimate the incidence of ASD as queried with CPT codes. A Kaplan-Meier curve would illustrate if this were happening, like the one shown in the paper by Shukla et al 2 this study from the same group shows that in a similar but significantly smaller pearldiver cohort, ~7.5% of the reoperations in an alif cohort occurred in the first few days after surgery, which would likely be accounted for by planned staged surgeries. ASD does not occur within days. …”
supporting
confidence: 62%
“…A Kaplan-Meier curve would illustrate if this were happening, like the one shown in the paper by Shukla et al 2 this study from the same group shows that in a similar but significantly smaller pearldiver cohort, ~7.5% of the reoperations in an alif cohort occurred in the first few days after surgery, which would likely be accounted for by planned staged surgeries.…”
“…The ICD/CPT codes used to query for ASD were not provided. Specific ICD codes do not exist at each lumbar level (unlike cervical disease), prohibiting querying for adjacent levels. The reported rates may be all-cause subsequent surgeries rather than solely surgeries for ASD secondary to index surgery. The study shows a ~7.5% difference in ASD rate, suggesting ALIF is significantly worse. This may stem from staged ALIF procedures, with the posterior approach occurring several days after the anterior approach. This would overestimate the incidence of ASD as queried with CPT codes. A Kaplan-Meier curve would illustrate if this were happening, like the one shown in the paper by Shukla et al 2 this study from the same group shows that in a similar but significantly smaller pearldiver cohort, ~7.5% of the reoperations in an alif cohort occurred in the first few days after surgery, which would likely be accounted for by planned staged surgeries. ASD does not occur within days. …”
supporting
confidence: 62%
“…A Kaplan-Meier curve would illustrate if this were happening, like the one shown in the paper by Shukla et al 2 this study from the same group shows that in a similar but significantly smaller pearldiver cohort, ~7.5% of the reoperations in an alif cohort occurred in the first few days after surgery, which would likely be accounted for by planned staged surgeries.…”
“…However, surgery involves not only secondary trauma but also many complications, such as fusion failure. [2][3][4] Although various new intervertebral fusion devices and bioactive bone substitute materials have been developed, their therapeutic effects are limited, and there is an urgent need to change the traditional surgical approach.…”
To reduce the risk of nonunion after spinal fusion surgery, the in situ transplantation of bone marrow mesenchymal stem cells (BMSCs) induced toward osteogenic differentiation by bone morphogenetic protein-2 (BMP2) has been proven effective. However, the current biological agents used for transplantation have limitations, such as a short half-life and low bioavailability. To address this, our study utilized a safe and effective gelatin-methacryloyl (GelMA) as a carrier for BMP2. In vitro, experiments were conducted to observe the ability of this composite vehicle to induce osteogenic differentiation of BMSCs. The results showed that the GelMA hydrogel, with its critical properties and controlled release performance of BMP2, exhibited a slow release of BMP2 over 30 days. Moreover, the GelMA hydrogel not only enhanced the proliferation activity of BMSCs but also significantly promoted their osteogenic differentiation ability, surpassing the BMP2 effects. To investigate the potential of the GelMA-BMP2 composite vehicle, a rabbit model was employed to explore its ability to induce in situ intervertebral fusion by BMSCs. Transplantation experiments in rabbits demonstrated the effective induction of intervertebral bone fusion by the GelMA-BMP2-BMSC composite vehicle. In conclusion, the GelMA-BMP2-BMSC composite vehicle shows promising prospects in preclinical translational therapy for spinal intervertebral fusion. It addresses the limitations of current biological agents and offers a controlled release of BMP2, enhancing the proliferation and osteogenic differentiation of BMSCs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.